JPM23 Roundup – 3 Biotechs with Philadelphia Ties Present at JP Morgan Healthcare Conference

Published on :

Numerous biopharma companies and organizations presented at the JP Morgan Healthcare conference held this week in San Francisco. Three with either headquarters in Philadelphia or ties to the area, were of note for their overview of 2022 and their outlook for 2023 and beyond. Here’s a look at presentations by Amicus Therapeutics, Avantor, and Jazz Pharmaceuticals.

Following Announcement of Layoffs, Century Therapeutics Outlines 3-Year Strategic Plan

Published on :

This year, 2023, Century is focused on the execution of its vision by advancing multiple development candidates, primarily the Phase I ELiPSE-1 clinical trial of CNTY-101 in patients with relapsed or refractory CD19+ B-cell malignancies.

Noble Life Sciences’ Latest Rebrand Brings Values to Life Through Color and Imagery

Published on :

In the hustle and bustle of planning experiments, growing a business and improving services, visual branding often stumbles toward the bottom of the priorities list for life science companies. While companies used to be able to get away with quickly putting a logo together and creating a scrappy website using a pre-existing Wix template, an increasingly crowded life sciences market is making leadership teams rethink their visual presence.

Why Baltimore Is Emerging as the Next Great City for Medtech

Published on :

Baltimore, MD is continuing to emerge as one of the next great cities for medtech and medical device innovation. That’s just one of the reasons that Maryland was selected to host MedTech Innovator  (MTI) and BioTools Innovator (BTI) for their East Coast pitch events on March 28-31, 2023. MTI and BTI are the largest and highest-performing global pitch competitions and accelerator programs for the life sciences field. Companies can apply before January 31st.

The Top 10 BioBuzz Feature Stories of 2022

Published on :

This past year was both exciting and challenging, as the world started to regain some normalcy following the COVID-19 pandemic. Mask mandates were lifted, travel restrictions lessened, and more companies reopened their offices for in-person work. While many of us are relieved by these recent changes, the pandemic has irreversibly impacted our way of life and how we work, especially for those of us invested in the biotech industry. Public opinion on science and medicine has become increasingly more polarized and politicized, and conversations about vaccination have never been louder. Apart from outside voices, the industry has struggled under continued supply chain shortages, staffing issues, market woes, and layoffs.  

BioBuzz’s 2022 Top 5 “5 Questions With…”

Published on :

We at BioBuzz have always strived to center ourselves around the individuals who have worked to push the biohealth sphere to new heights. Our “5 Questions With…” series embodies this effort as we have highlighted professionals at all levels, from early career to the C-suite, from scientists to business developers to managers and directors. Regardless of position or title, the many individuals highlighted in 2022 are all changemakers in their own right and we greatly appreciate their work and contribution to this series. 

Kite to Bolster Cell Therapy Capabilities through Acquisition of Carl June’s Tmunity Therapeutics

Published on :

A Gilead Sciences company, Kite announced Tmunity’s next-generation CAR-T therapies and technology will complement its own cell therapy research capabilities. Kite’s acquisition of Tmunity, founded by Carl June, creates a strong bridge between the BioHealth Capital Region, where Kite maintains its manufacturing capabilities in Frederick, and the Greater Philadelphia biohub.

Meet Your 2022 BioBuzz Award Winners

Published on :

Today, we are excited to announce the winners of our 3rd Annual BioBuzz Awards. The BioBuzz Awards are a celebration of the exciting and groundbreaking work being done by the BioHealth Capital Region (BHCR) and Greater Philadelphia life science communities and the individuals that make innovation happen.

In Conversation: Kelly Schulz, CEO, Maryland Tech Council

Maryland Tech Council
Published on :

The Maryland Tech Council (MTC) is the largest support organization for technology and life sciences companies in the state. MTC creates and supports initiatives, from events to workforce development, that bring the entire Maryland tech and life sciences ecosystem together to advance innovation and foster growth.

2500 League Island Boulevard: The Future of Life Sciences Manufacturing Takes Shape in the Philly Navy Yard

Published on :

A new, purpose-built facility at 2500 League Island Boulevard in the heart of Philadelphia will bring much-needed world-class manufacturing and R&D space to a burgeoning life sciences ecosystem. The large building, 130,000 ft2 with 30 ft clear height, will accommodate the unique demands of life sciences manufacturing, as will its large floor slabs and abundant roof-top utilities.